BCG vaccination potential for COVID-19: an analytical approach
- PMID: 33769207
- PMCID: PMC8475566
- DOI: 10.1080/21645515.2021.1885281
BCG vaccination potential for COVID-19: an analytical approach
Abstract
In order to assess the possible protective potential of BCG vaccination as regards to COVID-19, we have analyzed BCG vaccination status and SARS CoV-2 morbidity and mortality in China and we have also examined other studies performed in other countries to assess the potential of booster doses of BCG vaccination for adults. We have concluded that BCG vaccination early in life is highly unlikely to be a tool that might prevent SARS CoV-2 infection in adults. Furthermore, we have suggested that BCG vaccination potential benefit to decrease COVID-19 morbidity and mortality in children is confounded by many factors, e.g. age limitations of exposure and other vaccines. However, BCG vaccination booster doses in adults might be of protective value until the results of well-designed clinical trials are published to confirm, or refute, this potential.
Keywords: BCG vaccination; COVID-19; SARS CoV-2.
Figures
Similar articles
-
Effectiveness of booster BCG vaccination in preventing Covid-19 infection.Hum Vaccin Immunother. 2021 Nov 2;17(11):3913-3915. doi: 10.1080/21645515.2021.1956228. Epub 2021 Aug 17. Hum Vaccin Immunother. 2021. PMID: 34403297 Free PMC article.
-
BCG vaccination at birth and COVID-19: a case-control study among U.S. military Veterans.Hum Vaccin Immunother. 2022 Dec 31;18(1):1981084. doi: 10.1080/21645515.2021.1981084. Epub 2021 Oct 13. Hum Vaccin Immunother. 2022. PMID: 34643480 Free PMC article.
-
BCG Vaccination Program Mitigates COVID19 Related Mortality: A Reality Check.Curr Pharm Biotechnol. 2021;22(12):1574-1583. doi: 10.2174/1389201022666210202142811. Curr Pharm Biotechnol. 2021. PMID: 33530904 Review.
-
Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.Trials. 2020 Sep 17;21(1):799. doi: 10.1186/s13063-020-04714-3. Trials. 2020. PMID: 32943115 Free PMC article.
-
Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.Asian Pac J Allergy Immunol. 2020 Sep;38(3):150-161. doi: 10.12932/AP-310520-0863. Asian Pac J Allergy Immunol. 2020. PMID: 32686943 Review.
Cited by
-
Recombinant Bacillus Calmette-Guérin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge.J Immunol. 2023 Jun 15;210(12):1925-1937. doi: 10.4049/jimmunol.2200731. J Immunol. 2023. PMID: 37098890 Free PMC article.
-
The African Kelleni's roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one.Inflammopharmacology. 2023 Dec;31(6):3335-3338. doi: 10.1007/s10787-023-01263-4. Epub 2023 Jun 16. Inflammopharmacology. 2023. PMID: 37326756 Free PMC article.
-
Effectiveness of booster BCG vaccination in preventing Covid-19 infection.Hum Vaccin Immunother. 2021 Nov 2;17(11):3913-3915. doi: 10.1080/21645515.2021.1956228. Epub 2021 Aug 17. Hum Vaccin Immunother. 2021. PMID: 34403297 Free PMC article.
References
-
- WHO . Global tuberculosis report 2019; 2019October17. [accessed 2021 Jan 10]. https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-en....
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous